Total Payments
$1,748
2024 Payments
$214.68
Companies
23
Transactions
119
Medicare Patients
540
Medicare Billing
$56,930
Payment Breakdown by Category
Food & Beverage$1,738 (99.4%)
Education$10.52 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,738 | 118 | 99.4% |
| Education | $10.52 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $613.51 | 41 | $0 (2024) |
| PFIZER INC. | $147.11 | 11 | $0 (2024) |
| Amgen Inc. | $142.80 | 10 | $0 (2024) |
| Lilly USA, LLC | $107.71 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $99.08 | 7 | $0 (2024) |
| Novo Nordisk Inc | $91.27 | 7 | $0 (2021) |
| Merck Sharp & Dohme LLC | $86.05 | 5 | $0 (2024) |
| ABBVIE INC. | $65.16 | 4 | $0 (2023) |
| Abbott Laboratories | $56.67 | 3 | $0 (2022) |
| Corium, LLC | $50.37 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $214.68 | 14 | AstraZeneca Pharmaceuticals LP ($51.20) |
| 2023 | $143.03 | 9 | Merck Sharp & Dohme LLC ($36.82) |
| 2022 | $244.86 | 15 | AstraZeneca Pharmaceuticals LP ($93.50) |
| 2021 | $402.50 | 26 | AstraZeneca Pharmaceuticals LP ($150.15) |
| 2020 | $105.68 | 8 | AstraZeneca Pharmaceuticals LP ($49.32) |
| 2019 | $181.74 | 13 | AstraZeneca Pharmaceuticals LP ($109.98) |
| 2018 | $234.57 | 17 | AstraZeneca Pharmaceuticals LP ($75.83) |
| 2017 | $221.29 | 17 | AstraZeneca Pharmaceuticals LP ($53.23) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: VACCINE | ||||||
| 11/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: VACCINES | ||||||
| 02/13/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Obesity | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2023 | Merck Sharp & Dohme LLC | VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: VACCINE | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Vaccines | ||||||
| 03/07/2023 | Merck Sharp & Dohme LLC | VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: VACCINE | ||||||
| 01/31/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: VACCINES | ||||||
| 01/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 208 | 367 | $48,105 | $23,701 |
| 2022 | 7 | 197 | 368 | $48,037 | $22,784 |
| 2021 | 3 | 48 | 59 | $7,746 | $4,579 |
| 2020 | 4 | 87 | 127 | $15,212 | $5,867 |
Total Patients
540
Total Services
921
Medicare Billing
$56,930
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 86 | $15,050 | $6,989 | 46.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 53 | $13,250 | $5,843 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 77 | $11,550 | $4,800 | 41.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $2,875 | $2,795 | 97.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $1,355 | $1,224 | 90.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 25 | $2,500 | $851.80 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 73 | $730.00 | $613.20 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $795.00 | $582.94 | 73.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 61 | $15,250 | $7,405 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 86 | $15,050 | $7,398 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 78 | $11,700 | $4,941 | 42.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 22 | $1,650 | $1,508 | 91.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 29 | $2,900 | $1,082 | 37.3% |
| 90471 | Administration of vaccine | Office | 2022 | 18 | 21 | $777.00 | $239.34 | 30.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 38 | 71 | $710.00 | $209.94 | 29.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 19 | $4,484 | $2,692 | 60.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 18 | $3,042 | $1,822 | 59.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 18 | 22 | $220.00 | $66.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 38 | $5,966 | $2,258 | 37.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 26 | $5,512 | $2,222 | 40.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 32 | $3,424 | $1,294 | 37.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 25 | 31 | $310.00 | $92.16 | 29.7% |
About Dr. Julie Reeves, MD
Dr. Julie Reeves, MD is a Family Medicine healthcare provider based in Medina, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205851318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Reeves, MD has received a total of $1,748 in payments from pharmaceutical and medical device companies, with $214.68 received in 2024. These payments were reported across 119 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,738).
As a Medicare-enrolled provider, Reeves has provided services to 540 Medicare beneficiaries, totaling 921 services with total Medicare billing of $56,930. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Medina, OH
- Active Since 07/12/2006
- Last Updated 05/17/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205851318
Products in Payments
- FARXIGA (Drug) $534.20
- SHINGRIX (Biological) $99.08
- ELIQUIS (Drug) $82.96
- Prolia (Biological) $80.62
- UBRELVY (Drug) $65.16
- TRULICITY (Drug) $60.20
- FREESTYLE LIBRE 2 (Device) $56.67
- Azstarys (Drug) $50.37
- Ozempic (Drug) $47.77
- MOUNJARO (Drug) $47.51
- SYMBICORT (Drug) $42.44
- AIRSUPRA (Drug) $36.87
- NURTEC ODT (Drug) $36.83
- VAXELIS (Biological) $36.82
- TRINTELLIX (Drug) $32.30
- GARDASIL 9 (Biological) $30.07
- Vascepa (Drug) $29.93
- CONTRAVE (Drug) $28.48
- INVOKANA (Drug) $24.65
- CHANTIX (Drug) $24.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Medina
Dr. Lisa Esterle, D.o, D.O
Family Medicine — Payments: $11,624
Family Medicine $11,624
Dr. Glenna Jackson, M.d, M.D
Family Medicine — Payments: $5,850
Family Medicine $5,850
Dr. Andrew Chema, M.d, M.D
Family Medicine — Payments: $4,546
Family Medicine $4,546
Catherine Taras, Md, MD
Family Medicine — Payments: $2,444
Family Medicine $2,444
Luan Oconnor, Do, DO
Family Medicine — Payments: $1,792
Family Medicine $1,792
Stephen Cullen, Md, MD
Family Medicine — Payments: $1,049
Family Medicine $1,049